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News and Events         June 2012 
From the University of Massachusetts Center for Clinical & Translational Science 
“Ask the Expert” Brown Bag Lunch – The Myths and Facts about Cancer Clinical Trials 
 
Please join us on Wednesday, June 20 from 12:00-12:30PM, for the Clinical Research “Ask 
the Expert” Brown Bag Lunch.  Andrew M. Evens, DO, MS will present, “The Myths and Facts 
about Cancer Clinical Trials”.  Dr. Evens is the Medical Director of the Cancer Research 
Office at the UMass Memorial Cancer Center of Excellence.  The presentation will take place in 
the Conquering Diseases Community Resource Center, 1st floor of the Ambulatory Care 
Center, University Campus, Worcester.  RSVP to Marybeth.curnen@umassmed.edu or call 
508-856-2557.  Patients and families are welcome to attend!
 
A reminder from Sheila Noone, Assistant Vice Provost for Clinical Research, about 
supports and guidance available to CCTS members and UMass faculty:  
 
The clinical trials suite in the Clinical Research Center can assist in the planning, initiation and 
conduct of your clinical trial.  Currently serving 24 investigators across 14 divisions/departments, 
the ambulatory suite is a participant-friendly unit with 6 exam rooms, 3 infusion areas for study 
visits; lab services for spinning, packaging & shipping are available; a -80 freezer for short-term 
storage, as well as comfortable areas for study meetings and monitor visits.  Fees for CRC 
services are dependent on your funding mechanism.  For a tour of the CRC’s trial suite and to 
learn more about services, please call Celia Hartigan, Nurse Manager at x63676 or x62800. 
Follow this link for further info: 
http://www.umassmed.edu/uploadedFiles/research/clinical/CRCService%20AgreementJune%2
02012%20dotx.pdf  
 
The Community Resource Specialist in the Clinical Research Center, Marybeth Curnen, is 
a wonderful resource for visitors and patients in the UMass Memorial system who are seeking 
information about clinical research and trials available at UMass or other research centers.  With 
a comfortable visitor-friendly area for exploring options on computers or through a guided 
search, the area also displays flyers and recruitment materials for interested visitors.  Please 
call Marybeth for further information at x62557.  Guidance for advertising your clinical 
studies is available on the clinical research website: 
http://www.umassmed.edu/uploadedFiles/research/clinical/ADVERTISING%20CLINICALRESE
ARCH%20STUDIES_June2012.pdf  
 
The Affordable Care Act:  A National Experiment 
June 19, 2012 
Tufts University, Boston 
Free Registration at: http://goo.gl/2Vi4M 
 
The purpose of this conference is to frame the 2010 Affordable Care Act (ACA) as one of the 
largest translational health policy experiments in our nation’s history.  NIH Clinical and 
Translational Science Awards (CTSAs) are charged with promoting translational research 
across the entire spectrum from bench-to-bedside (“T1 research”) through implementation in 
widespread practice and policy (“T3/T4 research”), aiming to advance the translation of medical 
science into impact on public policy and health.  This conference intends to highlight the 
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importance of the ACA and its innovations and resultant data, for informing healthcare 
improvement.
 
Italian Trade Commission/UMass Networking Reception at BIO 2012 
Tuesday, June 19, 2012 from 7:00 - 10:00 PM 
Federal Reserve Bank Building 
600 Atlantic Ave Boston, MA  
Please come meet the Italian Delegation at BIO and join us for a networking reception and 
dinner, promoted by the Italian Ministry of Economic Development.  RSVP at:  
http://italyumassbio2012.eventbrite.com/ 
 
Fifth Annual CTSA Consortium Community Engagement Conference 
Methods, Metrics and Outcomes: Evaluating the Success of Community Engaged 
Research 
August 23 – 24, 2012 
Bethesda North Marriott Hotel & Conference Center 
Bethesda, MD 
 
Conference goals are to demonstrate feasible and replicable methods and metrics developed by 
and with communities that have improved individual and community health, particularly within 
underserved communities; facilitate the application of these methodologies and metrics to 
diverse local settings; and share tools for assessing and improving the effectiveness of 
community engagement in improving individual and community health outcomes. 
 
3rd Conference on Clinical Research for Rare Diseases 
 
The Rare Diseases Clinical Research Network (RDCRN) and the Clinical and Translational 
Science Awards (CTSA) are sponsoring the 3rd Conference on Clinical Research for Rare 
Diseases (CCRRD) on Tuesday October 2, 2012 in Rockville, Maryland.  This unique 
conference will focus on research methodology for rare diseases and should be of particular 
interest to trainees and junior faculty engaged in research in rare diseases.  For more 
information about the conference, including details about the program, applying for travel 
awards, and conference logistics and registration, visit the conference website: 
https://rarediseasesnetwork.epi.usf.edu/conference/ 
Discovering New Therapeutic Uses for Existing Molecules 
 
NCATS has just announced a new pilot program to explore new therapeutic uses for existing 
molecules.  Eight participating companies have provided their compounds and related data, 
which were determined by the NIH to meet specific eligibility criteria. For example, each 
compound must have advanced to clinical studies but been unsuccessful in its original 
therapeutic indication or not pursued for business reasons. Preliminary information about the 58 
compounds, including mechanism of action, route of administration, and any limitations in use 
based on safety and tolerability, are available at http://ncats.nih.gov/therapeutics-directory.html. 
Researchers who are interested in NCATS’ Therapeutics Discovery funding must submit a pre-
application in response to the NIH Funding Opportunity Announcement at 
http://grants.nih.gov/grants/guide/pa-files/PAR-12-203.html by Aug. 14, 2012. 
 
Investigators interested in applying for this program should contact Nate Hafer at 
nathaniel.hafer@umassmed.edu or 508-856-2511 for complete details. 
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CVIP UMass Start-Up Initiative  
 
The Office of Commercial Ventures and Intellectual Property (CVIP) in the President’s Office 
has instituted the UMass Startup Initiative (UMSI) to foster the creation of startups at UMass.  
This program augments other funding initiatives which currently include the CVIP Technology 
Development Award and the UMass Co-Investment Equity Fund.  The UMSI will make five 
thousand dollar ($5,000) grants available to the UMass campuses to prepare business plans 
that address the commercial potential of inventions disclosed to CVIP.  The business plan will 
be prepared by an external consultant with relevant commercial experience working closely with 
the key investigator of the disclosed invention.  CVIP will assist with the selection of the 
consultant.  The business plans will be used by CVIP to determine the feasibility of a startup 
and after that determination CVIP will assist in seeking management and then investment for 
the new companies.  Initially the awards will be available on a request basis.   All applicants will 
be asked to submit a brief application describing the technology, its commercial application and 
the rationale for creating a startup.  Selection of the awardees will be made by CVIP with the 
assistance of an external advisory group.   
 
For full details and application instructions click on:  
http://www.umassmed.edu/uploadedFiles/CTS/Included_Content/CVIP_UMass_StartUp_Initiati
ve.pdf 
 
Please contact Drs. Bill Rosenberg, Executive Director, CVIP at wrosenberg@umassp.edu 
or Nate Hafer at nathaniel.hafer@umassmed.edu for questions/assistance. 
 
New Patient-Centered Outcomes Research Institute (PCORI) Funding Opportunities 
 
1. Patient-Centered Outcomes Research Institute (PCORI) Assessment of Prevention, 
Diagnosis, and Treatment Options: up to $500K/yr x 3 yrs.  LOI deadlines 6/15/12, 10/15/12, 
2/15/13, for projects that address critical decisions that patients, their caregivers and 
clinicians face with too little information.  Approximately 54 projects totaling up to $48 million 
in total costs may be funded under this PFA. 
2. Patient-Centered Outcomes Research Institute (PCORI) Improving Healthcare Systems: up 
to $500K/yr x 3 yrs.  LOI deadlines 6/15/12, 10/15/12, 2/15/13, for projects that address 
critical decisions that face health care systems, the patients and caregivers who rely on 
them, and the clinicians who work within them.  Approximately 27 projects totaling up to $24 
million may be funded under this PFA. 
3. Patient-Centered Outcomes Research Institute (PCORI) Communication and Dissemination 
Research: up to $500K/yr x 3 yrs.  LOI deadlines 6/15/12, 10/15/12, 2/15/13, for projects 
that address critical elements in the communication and dissemination process among 
patients, their caregivers and clinicians.  Approximately 14 projects totaling up to $12 million 
in total costs may be funded under this PFA. 
4. Patient-Centered Outcomes Research Institute (PCORI) Addressing Disparities: up to 
$500K/yr x 3 yrs.  LOI deadlines 6/15/12, 10/15/12, 2/15/13, for projects that will inform the 
choice of strategies to eliminate disparities.  Approximately 14 projects totaling up to $12 
million in total costs may be funded under this PFA. 
 
Please remember to cite the UMCCTS grant UL1RR031982 and UL1TR000161 in all 
journal publications. 
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